Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Clearside Biomedical Inc shares valued at $13,800 were purchased by Thorp Clay on Feb 24 ’25. At $0.92 per share, Thorp Clay acquired 15,000 shares. The insider’s holdings grew to 176,141 shares worth approximately $0.14 million following the completion of this transaction.
Also, Chong Ngai Hang Victor purchased 36,500 shares, netting a total of over 36,500 in proceeds. Following the buying of shares at $1.00 each, the insider now holds 100,000 shares.
Before that, Chong Ngai Hang Victor had added 23,500 shares to its account. In a trade valued at $24,910, the Chief Medical Officer bought Clearside Biomedical Inc shares for $1.06 each. Upon closing the transaction, the insider’s holdings increased to 23,500 shares, worth approximately $50165.0.
As published in their initiating research note from Chardan Capital Markets on August 21, 2024, Clearside Biomedical Inc [CLSD] has been a Buy and the price target has been revised to $6. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in late June. Earlier on July 29, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for CLSD stock.
Analyzing CLSD Stock Performance
The stock’s lowest price that day was $0.78, but it reached a high of $0.81 in the same session. During the last five days, there has been a drop of approximately -2.24%. Over the course of the year, Clearside Biomedical Inc shares have dropped approximately -16.84%. Shares of the company reached a 52-week high of $1.1400 on 02/07/25 and a 52-week low of $0.7001 on 04/09/25.
Support And Resistance Levels for Clearside Biomedical Inc (CLSD)
According to the 24-hour chart, there is a support level at 0.7767, which, if violated, would cause prices to drop to 0.7633. In the upper region, resistance lies at 0.8067. The next price resistance is at 0.8233. RSI (Relative Strength Index) is 45.26 on the 14-day chart, showing neutral technical sentiment.
Is Clearside Biomedical Inc subject to short interest?
Stocks of Clearside Biomedical Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.13 million shares to 0.12 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.25 million shares. A decline of -101.11% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.81 of the overall float, the days-to-cover ratio (short ratio) decline to 0.81.
